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Examining( the( Sensitivity( and( Specificity( of( two( screening(
instruments:( odontogenic( or( temporomandibular( disorder(
pain?(
Abstract(
Introduction: Two orofacial pains that are clinically important to distinguish are 
odontogenic pain and temporomandibular disorders (TMD) pain. The aim of this study was 
to determine the sensitivity and specificity of two screening instruments in distinguishing 
between patients with these types of pain. 
Methods: A convenience sample of patients seeking care at an Endodontic clinic and an 
Orofacial Pain clinic were recruited. The 14-item Dental Pain Questionnaire (DePaQ) was 
used to screen for odontogenic pain and the 6-item TMD-screener was used to screen for 
TMD pain. Sensitivity and specificity calculations, with 95% confidence intervals (CI), were 
performed for both instruments and thresholds/acceptability/performance was assessed using 
published guidelines. 
Results: Thirty-four patients with odontogenic pain and 37 patients with TMD pain were 
included in this study. The sensitivity of the DePaQ was 0.85 (95%CI: 0.69-0.95) and 
specificity was 0.11 (95%CI: 0.03-0.25). The sensitivity of the TMD screener was 0.92 
(95%CI: 0.78-0.98) and specificity was 0.59 (95%CI: 0.41-0.75). The point estimates, a 
single value used to estimate the population parameter, for both the DePaQ and TMD 
screener were “acceptable” in identifying patients who had the pain condition in question 
(i.e., sensitivity), while the point estimate for appropriately identifying patients who did not 
have the pain condition when they did not have it (i.e., specificity) was “non-acceptable” for 
both.  
Conclusion: The DePaQ and the TMD Screener lack diagnostic accuracy for differentiating 
TMD from odontogenic tooth pain without adjunctive (clinical) investigation(s) or 
examination. The TMD screener, however, has high sensitivity for identifying true positives 
i.e. TMD pain, and would therefore be useful as a screening instrument when one can 
exclude odontogenic pain definitively on clinical and radiographical grounds for instance in 
endodontic practices. In this study the negative predictive value was also high in the TMD 
screener and therefore we can trust a negative result: that is when the TMD screener is 
negative we can be fairly certain the pain diagnosis is not TMD and rule out TMD. 
2 
Introduction 
Tooth pain is the most prevalent pain complaint in the orofacial region, with a 12% 
prevalence (1). The majority of tooth pain is of odontogenic origin (2), that is 
inflammation in and around the tooth and this pain is one of the most common reasons 
patients seek dental care (3-5). The term odontogenic pain encompasses a number of 
potential diagnoses: symptomatic irreversible pulpitis as a pulpal diagnosis; symptomatic 
apical periodontitis and acute apical abscess as apical diagnoses (6).  
A complaint of "tooth" pain may in fact have a non-odontogenic origin as a result of 
referred pain from other structures. For example temporomandibular disorders (TMD) are 
known to refer pain to the dentoalveolar structures (7, 8). From the patients that visit the 
dental office because of “tooth” pain, a sizeable proportion (12-50%), have a non-
odontogenic or mixed origin for their pain (7, 9-11). The most common non-odontogenic 
reason for “tooth” pain is pain related to a TMD, which arises from muscle of 
mastication, temporomandibular joints, and/or associated structures (11-13).  
As odontogenic pain is common it is something dentists are experienced in 
diagnosing and managing. Occasionally, despite being an odontogenic complaint, tests 
for dental pathology are negative and dentists need to consider non-odontogenic reasons 
for the pain. Having a brief valid screening instrument to aid in identifying the most 
common non-odontogenic reason for “tooth” pain may be helpful in identifying such 
patients within regular dental practice. Therefore, the aim of this study was to examine 
the sensitivity and specificity of two screening questionnaires, one designed for 
odontogenic pain (DePaQ) and one for TMD related pain (TMD screener), in patients 
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experiencing pain of either odontogenic or TMD origin. The secondary aim of this study 
was to explore the performance of the screening questions in subsets of patients, those 
where TMD pain is referred to the dentoalveolar region and presents as “tooth” pain. This 
assessment is to explore whether this subgroup performs differently compared to patients 
experiencing regular TMD pain. 
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Methods(
This cross-sectional study is derived from data collected within a parent study 
designed to explore item selection for the development of a Persistent Dentoalveolar Pain 
disorder (PDAP) screening questionnaire. Ethics approval from the University of 
Minnesota was obtained and all the participants provided informed consent prior to their 
participation. The Standards for Reporting Diagnostic accuracy studies (STARD) criteria 
were used for reporting results (14). 
Participants(
Recruitments of patients were performed by board certified Orofacial Pain 
practitioners and a board certified Endodontist. TMD pain patients were recruited from 
the TMD and Orofacial Pain Clinic in the School of Dentistry at the University of 
Minnesota, Minneapolis, Minnesota. Odontogenic pain patients were recruited in a 
private endodontic practice, The Dental Specialists, within the Twin Cities area. A 
convenience sample of these two groups of patients was collected. Some patients with 
TMD pain perceived their pain in the jaw and face, while others perceived their pain in a 
tooth/alveolus, as referred from other structures. These differences in the two subgroups 
will be covered in greater detail below. 
Enrollment(criteria(
The following criteria were used to select patients for this study. 
Inclusion(Criteria(
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Odontogenic pain sample: Patients diagnosed with symptomatic irreversible pulpitis, 
symptomatic apical periodontitis, and/or symptomatic apical abscess following American 
Association of Endodontists diagnostic criteria (15, 16). 
TMD pain sample: Patients with diagnosis of TMD pain, including myalgia, 
myofascial pain with referral or arthralgia following the diagnostic criteria for TMD 
(DC/TMD) (17). Among the TMD sample, patients presenting with referred pain to 
surrounding areas (myofascial pain with referral) were accepted. This meant within the 
TMD pain sample there were two subgroups one with referral of pain to the dentoalveolar 
region, as described by Wright (12), and one without referral to this region. These 
subgroups were purposively selected due to the increased potential for diagnostic 
confusion. 
Patients included in the sample had to be: seeking treatment for their painful condition in 
one of the clinics of the study; aged 18 years old and older; conversant in English. 
Exclusion(Criteria:(
Patients were excluded from the study if they presented with both an odontogenic and 
a TMD pain diagnosis, had another comorbid orofacial pain diagnosis, had a history of 
traumatic injuries to the orofacial region, had a major systemic illness related to altered 
pain sensitivity such as rheumatoid arthritis, fibromyalgia and other widespread bodily 
pain conditions, had a history of TMJ surgery or inter-articular steroid injection, were 
unable to give informed consent, or had been involved in a prior qualitative research 
study to generate questionnaire items for the parent study (18, 19). 
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Sample(Size(
The number of patients per pain group was calculated to be 35 per group and slight 
over-recruitment was intended to allow for a low expected dropout rate. 
Screening(questionnaires(used(
Dental(pain(screening(questionnaire(
The DePaQ (Appendix 1) was used as the instrument to detect patients with 
odontogenic pain given its widespread usage in the literature (20-23). It is a 14-item 
questionnaire developed in the United Kingdom, designed to differentiate three groups of 
odontogenic tooth pain:  
− Group A: Irreversible pulpitis and acute apical periodontitis. 
− Group B: Reversible pulpitis and dentine hypersensitivity. 
− Group C: Pericoronitis. 
The item generation study of this questionnaire was developed within a sample of 313 
patients, where just over 50% were male. The sample consisted of Group A patients-35%, 
Group B-32%, and Group C-18%. Its original validation study (23) demonstrated 
sensitivity (95% CI) of: 80% (71 to 87%) for Group A, 85% (62 to 97%) for Group B and 
59% (36 to 80%) for Group C; specificity of 83% (69 to 93%), 89% (83 to 94%) and 
90% (84 to 95%) respectively.  
TMD(screening(questionnaire(
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The TMD screener (Appendix 2) was developed as a self-report instrument in 
screening patients for pain-related TMD (24). It was designed in a long (six-item) and 
short (three-item) versions using psychometric methods for item selection, and evaluated 
for validity among 504 participants. It compared pain-related TMD versus healthy 
controls; versus non-painful TMD; and versus headaches. Among the results, in all the 
groups and both questionnaires, the sensitivity was 99%, where specificity was 97% in 
the long version and slightly lower at 95% in the short version. In our study we focused 
on assessing the long version, which is expected to perform best, and presented data on 
the short version for completeness. 
Data(management(and(statistical(analyses(
Data entry was performed by two of the participating clinicians and was cross-
checked for accuracy by a third investigator. Data were managed using the spreadsheet 
software Microsoft Excel (Microsoft Excel 2010 for PC: Microsoft Corporation) and all 
analyses were performed using the statistical software package STATA (Stata Statistical 
Software: V12 for Mac. College Station, TX: StataCorp LP). 
The data were analyzed comparing all patients with known odontogenic pain with all 
patients with known TMD pain group using the two questionnaires. This was contrasted 
using two by two tables. Four subgroup analyses were performed, depending on the site 
where the pain was felt. The analyses were as follows: 
− Aim 1.0. Determine the sensitivity and specificity of the DePaQ for identifying all 
patients with odontogenic pain versus all patients with TMD pain as controls 
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- Subaim 1.1. Determine the sensitivity and specificity of the DePaQ for 
identifying all patients with odontogenic pain versus patients with TMD pain, 
excluding TMD pain referred to teeth as controls. 
- Subaim 1.2. Determine the sensitivity and specificity of the DePaQ for 
identifying all patients with odontogenic pain versus patients with TMD pain 
referred to teeth only as controls.  
− Aim 2.0. Determine the sensitivity and specificity of the TMD screening 
questionnaire for identifying all patients with TMD pain versus odontogenic pain 
patients as controls. 
- Subaim 2.1. Determine the sensitivity and specificity of the TMD screening 
questionnaire for identifying patients with TMD pain, excluding TMD pain 
referred to teeth, versus odontogenic pain patients as controls. 
- Subaim 2.2. Determine the sensitivity and specificity of the TMD screening 
questionnaire for identifying patients with TMD pain referred to teeth only 
versus odontogenic pain patients as controls. 
Results are presented as point-estimates, a single value used to estimate the population 
parameter, for the sensitivity and specificity of the questionnaires for each comparison 
with 95% confidence intervals presented to demonstrate the level of precision these 
calculations offer.  
Levels of diagnostic accuracy were assessed using sensitivity and specificity 
estimates described by Dworkin and LeResche (acceptable sensitivity=70% and 
acceptable specificity=95%)(25). 
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Results(
Description(of(patients((
A total of 82 patients participated in this study but 11 of them were excluded due to: 
volume of missing data in either of the screening instruments (n=5; of which 4 were 
TMD) and diagnosis of comorbid TMD with odontogenic pain (n=6). The demographics 
of the patients enrolled are presented in Table 1. 
Of the 71 patients included, 34 (47%) of them had odontogenic pain: 5 (15%) with 
symptomatic irreversible pulpitis only, 17 (50%) with symptomatic apical periodontitis 
only, 6 (18%) with acute apical abscess, and 6 (18%) with symptomatic irreversible 
pulpitis and symptomatic apical periodontitis.  
Thirty-seven patients were recruited to the TMD pain group: 17 (46%) with myofascial 
pain, 2 (5%) with arthralgia, and 18 (49%) with myofascial pain and concomitant 
arthralgia. Figure 1 demonstrates the subdivision of the TMD pain group into pain 
referred to dentoalveolar structures (n=12 within TMD pain group). 
Diagnostic(accuracy(of(questionnaires(
Using the DePaQ as the screening instrument, to discriminate between odontogenic 
pain group versus the whole TMD pain group, the sensitivity obtained was 0.85 
(95%CI=0.69-0.95), and the specificity was at 0.11 (95%CI=0.03-0.25). When the TMD 
pain sample was divided in the two subgroups depending on whether TMD pain was 
referred to teeth or not, in both cases sensitivity remained the same and only specificity 
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changed. When comparing odontogenic pain versus TMD pain not referring to teeth, 
specificity increased to 0.12 (95% CI=0.03-0.31). When comparing odontogenic pain 
versus TMD pain referring to teeth only, specificity decreased to 0.08 (95% CI=0.002-
0.38). Table 2 shows additional details. 
When the 6-item TMD screener was the questionnaire used to compare the 
odontogenic pain group versus the whole TMD pain group, it showed a sensitivity of 0.92 
(95%CI=0.78-0.98), and specificity of 0.59 (95%CI=0.41-0.75). When the TMD pain 
sample was divided in the two subgroups where TMD pain was referred to teeth or not, in 
both cases specificity remained the same and only sensitivity changed. When comparing 
odontogenic pain versus TMD pain not referring to teeth, the confidence interval widened 
0.92 (95% CI=0.74 to 0.99), while when comparing odontogenic pain versus TMD pain 
referring to teeth only, sensitivity and specificity were 0.92 (95%CI:0.61-1.00) and 0.59 
(95%CI:0.41-0.75) respectively. Table 2 shows additional details. When the 3-item TMD 
screener was used to compare the odontogenic pain group versus the whole TMD pain 
group, it showed a sensitivity of 0.99 (95%CI=0.86-0.99), and specificity of 0.22 
(95%CI=0.10-0.38). 
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Discussion(
The purpose of this study was to test whether either screening questionnaire, one used 
to identify odontogenic pain and one used to identify TMD pain, can adequately separate 
patients with these orofacial pain conditions. The results indicate that both 
questionnaires, the DePaQ and the TMD screener, have an acceptable sensitivity whilst 
the specificity is unacceptable for both screening questionnaires according to the criteria 
used(25). This means that DePaQ will identify those patients that have odontogenic pain 
most of the time, 85%, when they have odontogenic pain and the TMD screener will 
identify those patients that have TMD pain most of the time, 92%. Nevertheless the 
questionnaires perform less well in identifying patients as not having the disorder when 
they do not have it. The DePaQ, with a specificity of 11% will classify 89% of the 
patients with TMD as patients having odontogenic pain. Such a high false positive rate 
limits this questionnaire’s use in populations with both TMD pain and/or odontogenic 
pain. The 6-item TMD screener, with a specificity of 59%, will classify 41% of the 
patients with odontogenic pain as having TMD pain; while the 3-item TMD screener, 
with a specificity of 22%, will classify 78% of the patients with odontogenic pain as 
having TMD pain. Furthermore, the TMD screener and the DePaQ do not seem to be 
influenced by the site of pain because subset analyses yielded very similar sensitivity and 
specificity results when patients with TMD pain perceived to be of tooth origin only were 
compared to TMD pain patients perceived to be in the jaw. This is encouraging because 
some TMD pain patients do not seem able to distinguish between different locations of 
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their TMD pain(26) and dentists have been reported to misinterpret TMD pain perceived 
as “tooth” pain as being odontogenic in origin(8). 
Comparison(of(patient(population(with(other(studies(
It is difficult to compare our enrolled patients with those enrolled with the studies 
used to develop the questionnaires because the description of the populations used in 
these studies is sparse. Verifying the population as “typical” for TMD and odontogenic 
pain would help to understand the results. For comparison purposes, the characteristics of 
our sample of patients seems to be similar to larger studies seeking to have representative 
patients with TMD(27) and odontogenic pain(28) is interesting (compare Table 1 with 
Table 3, which depicts the characteristics of the patients within each of these two 
studies). Given the similar sociodemographic profile of our sample of patients with these 
other studies, it is likely we have examined the instruments in a fairly representative 
sample of patients. 
Comparison(of(diagnostic(accuracy(with(previous(studies(
The DePaQ demonstrated acceptable sensitivity at 0.85 and this was comparable to its 
results in its validation studies(23). The specificity results in our study, however, showed 
an unacceptable specificity, 0.11 which was substantially smaller than that identified in 
the validation studies (0.83). The DePaQ is widely recommended as a screening test for 
odontogenic pain, however, the assessment of referred pain from other sources felt in the 
teeth was neglected when the questionnaire was developed. In fact, previous studies only 
13 
compared different types of tooth pain, and did not compare these to other pains in the 
face/head that could confuse patient and practitioner when describing/giving a diagnosis.  
The DePaQ was developed to classify patients into three different groups, depending 
on their condition, thereby attempting to facilitate the assessment of dental treatment 
needs. It has been seen in this study that there was a high probability of false positive 
results, in case of a non odontogenic origin of the pain, potentially resulting in a risk of 
mistreatment. 
The use of the DePaQ as a screening instrument for patients complaining of “tooth” 
pain may cause confusion to patients and practitioners when it scores positive for 
odontogenic pain and teeth are not the cause of the pain. Given the low specificity score, 
this questionnaire is not recommended for use to differentiate between odontogenic pain 
and TMD pain. 
The 6-item TMD screener scored 0.92 in sensitivity, slightly less than in the 
development and validation study, but still acceptable. This slight difference is expected 
because the score is expected to decrease when the questionnaire is tested in a different 
population from one that was used to derive it. During the original development of the 
TMD screener, odontogenic pain patients were included(24), which is an expected source 
of diagnostic confusion and likely the reason why our observed specificity of 59% was 
less than their values ranging from 95% to 98%(24). The specificity is especially 
reduced, down to 22%, when the 3-item version of the TMD screener is used; which 
suggests that the longer version is preferred when it is to be used with such patient 
populations. 
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Considerations(regarding(prevalence(and(clinical(usefulness(
We have interpreted sensitivity and specificity because these measures of diagnostic 
test accuracy are assumed to be relatively stable across populations. However, the clinical 
usefulness of the test in a particular setting is determined through its predictive values 
and they depend on the prevalence of the disease. For example, for a prevalence of TMD 
in this study cohort of 52% (37/71 patients), TMD screener’s PPVs was 71%, indicating 
that 71 of 100 patients with a positive test result do indeed have the disease. The 
confidence interval for the PPV for the TMD screener also indicated that a result of only 
56 of 100 patients was also compatible with our study findings. In settings with lower 
prevalence of the disease, PPV would be even lower, indicating that a positive test result 
cannot be trusted. Only NPV was high for the TMD screener, indicating that a negative 
test result can be trusted. 
Items(analysis(as(potential(to(improve(diagnostic(test(accuracy((
Performing an item analysis can help identify the discriminative properties of 
individual questions within the screeners. Table 4 presents the mean answers to the 
DePaQ and to the TMD screener for each item, as well as Fischer’s coefficients for each 
question for a positive result for odontogenic pain in the DePaQ. The results of the item 
analysis are relevant in three questions: 
1. Question number 2 in the DePaQ relating to duration of the pain had a mean(SD) 
result of 2.3(1) for odontogenic pain and 4.2(0.9) for TMD pain not referring to 
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teeth, and 4.2(1.1) for TMD pain referring to teeth. This means that the way this 
question is formulated helps to separate odontogenic pain from TMD pain.  
2. Question number 1 in the TMD screener, relating to the duration of the pain, had 
results for the three groups that were similar.  The mean scores (SD) were 1.1(0.8) 
for odontogenic pain, 1.4(0.5) for TMD pain not referring to teeth and 1.3(0.6) for 
TMD pain referring to teeth. This shows that the wording of this question is not 
sufficient to separate these different sources of pain. 
3. Question number 3 in the TMD screener, relating to having pain when chewing 
hard and tough food, had a mean score(SD) of 0.8(0.4) for odontogenic pain, 
1(0.2) for TMD pain not referring to teeth, and 1(0) for TMD pain referring to 
teeth. This indicates that all the groups have pain when chewing, and that 
odontogenic pain patients cannot differentiate between originating from muscle of 
mastication and/or TMJ verses teeth. 
Together, these findings indicate that the TMD screener may be used as an adjunct, 
but not sufficient, for differentiating TMD pain from odontogenic pain. 
Limitations!
Our sample size was limited and therefore confidence intervals for diagnostic 
accuracy measures’ point estimates were wide. Larger subgroups, such as TMD pain 
referred to teeth, would, therefore, be helpful in adding confidence that what we observed 
is not a spurious finding due to the clinic setting from which these patients were 
recruited. Furthermore having a third group that had both odontogenic pain and TMD 
pain would be helpful in elucidating how these screening questionnaires performed in the 
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presence of comorbid pain conditions. It is also conceivable that patients with anterior 
tooth pain verses posterior tooth pain may answer questions differently as might patients 
with primarily a pulpal diagnosis for their pain, such as symptomatic irreversible pulpitis, 
as opposed to patients with apical diagnoses for their pain, such as necrotic pulp and 
symptomatic apical periodontitis (15). 
Conclusion(
Both the DePaQ and the TMD screener have acceptable sensitivity, but unacceptable 
specificity. The extremely low result in the specificity in the DePaQ and 3-item TMD 
screener means that they are not suitable for use for diagnostic purposes in populations 
that are known to have TMD pain because it will misdiagnose people with odontogenic 
pain as having TMD. For epidemiological studies designed to gauge the magnitude of 
tooth pain prevalence, these questionnaires can still be used because the known error 
rates can be used to recalculate the prevalence. A word of caution for this should be given 
because there is considerable uncertainty in the estimate, due to the large confidence 
intervals, and therefore this approach may have limited utility. The 6-item TMD screener, 
because it has modest specificity and excellent sensitivity, has the best potential for use in 
distinguishing people with odontogenic pain from TMD pain in clinical settings where 
TMD prevalence is not very low and for use in epidemiological studies. 
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Table(1:(Characteristics(of(the(71(patients(enrolled(in(the(study(
 
Odontogenic pain 
n=34 
TMD pain 
n=37 
! Mean%(SD)%or% %(n)!
Age in years 49 (12) 45 (18) 
Gender: female 53 (18) 86 (32) 
Ethnicity: non-Hispanic 100 (34) 97 (36) 
Race: white 79 (27) 92 (34) 
Income ≥ $30,000 85 (29) 43 (16) 
Dental insurance: yes 94 (32) 81 (30) 
Level of education: college degree or more 53 (18) 46 (17) 
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Table&2:&
Diagnostic&accuracy&measures&of&the&different&groups&for&DePaQ&and&TMD&screener&
Diagnostic group 
Cell frequencies Prevalence of 
the target 
condition 
Sensitivity 
(CI) 
Specificity 
(CI) 
PPV 
(CI) 
NPV 
(CI) True positive 
False 
negative 
False 
positive 
True 
negative 
DePaQ 
AIM&1.0:&DePaQ&
Odontogenic pain versus all TMD 
pain 
29 5 33 4 0.48 0.85 (0.69 to 0.95) 
0.11 
(0.03 to 0.25) 
0.47 
(0.34 to 
0.60) 
0.44 
(0.14 to 
0.79) 
AIM&1.1:&DePaQ&
Odontogenic pain versus TMD pain 
not referring to teeth only 
29 5 22 3 0.58 0.85 (0.69 to 0.95) 
0.12 
(0.03 to 0.31) 
0.57 
(0.42 to 
0.71) 
0.37 
(0.09 to 
0.75) 
AIM&1.2:&DePaQ&
Odontogenic pain versus TMD pain 
referring to teeth only 
29 5 11 1 0.74 0.85 (0.69 to 0.95) 
0.08 
(0.002 to 0.38) 
0.72 
(0.56 to 
0.85) 
0.17 
(0.004 to 
0.64) 
TMD screener 
AIM&2.0:&TMD&Screener&
All TMD pain versus Odontogenic 
pain 
34 3 14 20 0.52 0.92 (0.78 to 0.98) 
0.59 
(0.41 to 0.75) 
0.71 
(0.56 to 
0.83) 
0.87 
(0.66 to 
0.97) 
AIM&2.1:&TMD&Screener&
TMD pain not referring to teeth only 
versus Odontogenic pain 
23 2 14 20 0.41 0.92 (0.74 to 0.99) 
0.59 
(0.41 to 0.75) 
0.62 
(0.45 to 
0.77) 
0.91 
(0.71 to 
0.99) 
AIM&2.2:&TMD&Screener&
TMD pain referring to teeth only 
versus Odontogenic pain 
11 1 14 20 0.26 0.92 (0.61 to 1.00) 
0.59 
(0.41 to 0.75) 
0.44 
(0.24 to 
0.65) 
0.95 
(0.76 to 
1.00) 
&
PPV: Positive predictive value; NPV: Negative predictive value; CI: Confidence interval=95% 
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Table&3:&Comparison&of&the&sample&with&other&populations&
 
*Income ≥$50,000 
  
 Nixdorf 2012 Schiffman 2010 
Odontogenic pain 
n=708 
TMD pain 
n=141 
Mean%(SD)%or% %(n) 
Age in years 48 (13) 39 (15) 
Gender: female 59 90 
Ethnicity: non-Hispanic 96 - 
Race: white 91 93 
Income ≥ $30,000 84 59* 
Level of education: 
college degree or more 
81 81 
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Table&4:&Item&analyses&for&DePaQ&and&TMD&screener&
Question number: topic of 
the question 
Fischer’s 
coefficient 
Score in the 
questionnaire 
Odontogenic 
pain 
TMD pain 
Not ref. to 
teeth 
TMD pain 
Referring to 
teeth 
Min-Max Mean (SD) 
DePaQ 
Question 1: Location 7.72  0-2 1.3 (0.5) 0.2 (0.5) 1.3 (0.6) 
Question 2: Duration 3.79 1-5 2.3 (1) 4.2 (0.9) 4.2 (1.1) 
Question 3: Intensity 4.28 1-5 3 (1.2) 3.2 (1.2) 3.2 (1.1) 
Question 4: Periodicity 3.79 1-2 1.3 (0.5) 1.4 (0.5) 1.5 (0.5) 
Question 5: Radiation 0.64 1-4 2.6 (0.9) 3 (0.9) 2.8 (0.8) 
Question 6: Chewing on 
side 1.13 1-5 4 (1) 3.2 (1.2) 3.4 (1.2) 
Question 7: Cold 
sensitivity 3.34 1-5 3.8 (0.8) 3.4 (0.7) 3.6 (0.9) 
Question 8: Gum swelling 0.29 1-5 2 (1.2) 1.2 (0.5) 1.7 (1) 
Question 9: Loose tooth 0.23 1-4 1.2 (0.7) 1.1 (0.4) 1.4 (1) 
Question 10: Difficulty to 
swallow -0.72 1-5 1 (0) 1.2 (0.6) 1.7 (1) 
Question 11: Sticking out 0.05 1-5 1.6 (1.1) 1 (0) 1.3 (0.9) 
Question 12: Difficulty 
sleeping 2.72 1-5 2.6 (1.2) 2.3 (1.4) 2.2 (1.3) 
Question 13a: Exhausting 0.03 0-1 0.3 (0.5) 0.4 (0.5) 0.7 (0.5) 
Question 13b: Electric -4.44 0-1 0.2 (0.4) 0.1 (0.3) 0.2 (0.4) 
Question 13c: Pulling -5.28 0-1 0.2 (0.4) 0.3 (0.5) 0.3 (0.5) 
Question 13d: Numb 4.88 0-1 0.3 (0.5) 0.2 (0.4) 0.3 (0.5) 
TMD screener 
Question 1: Pain duration - 0-2 1.1 (0.8) 1.4 (0.5) 1.3 (0.6) 
Question 2: Jaw stiffness - 0-1 0.3 (0.5) 0.8 (0.4) 0.9 (0.3) 
Question 3: Chewing food - 0-1 0.8 (0.4) 1 (0.2) 1 (0) 
Question 4: Opening mouth - 0-1 0.1 (0.3) 0.9 (0.3) 0.7 (0.4) 
Question 5: Clenching - 0-1 0.4 (0.5) 0.9 (0.3) 0.9 (0.3) 
Question 6: Talking - 0-1 0.1 (0.3) 0.8 (0.4) 0.4 (0.5) 
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Figures&
Figure&1:&Patients&enrolled&
 
SAP: Symptomatic apical periodontitis, SIP: Symptomatic irreversible pulpitis, AAA: Acute apical abscess, MFP: 
Myofascial pain.  
*Percentage from the Odontogenic pain group only. **Percentage from the TMD pain group only.  
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Appendix&1:&Dental&Pain&Questionnaire&
 
1. Where in the mouth and/or 
face region do you feel the 
pain you currently have? 
(You may tick more than 1 
answer) 
1 tooth/teeth (1)  
2 gums (1)  
3 tongue (0)  
4 palate (0)  
5 floor of mouth (0)  
6 inside of cheek (0)  
7 jaw (0)  
8 jaw joint (0)  
9 others (please specify: (0)                                )  
 
2. How long have you had your 
current pain? 
1 less than 1 week (1)  
2 1 week or longer, but less than 4 weeks (2)  
3 4 weeks or longer, but less than 6 months (3)  
4 6 months or longer, but less than 1 year (4)  
5 1 year or longer (5)  
 
3. How would you describe the intensity of your current pain 
AT ITS WORST? 
1 Mild  (1)  
2 Discomforting (2)  
3 Distressing (3)  
4 Horrible  (4)  
5 Excruciating (5)  
 
4. Thinking about your current pain, how would you describe 
its pattern of occurrence? 1 Episodic: It comes and goes (1)  
2 Continuous: It’s constant (2)  
 
 Not at all (1) 
A small 
extent (2) 
Moderate 
extent (3) 
A large 
extent (4) 
Complete 
extent (5) 
5. Please indicate the extent to which your pain 
radiates to the surrounding area:      
 
 Complete extent (5) 
A large 
extent (4) 
Moderate 
extent (3) 
A small 
extent (2) 
Not at all 
(1) 
6. Please indicate the extent to which it is worse 
when you chew or eat on the side of your 
mouth with the pain: 
     
 
 
Makes it a 
lot more 
painful (5) 
Makes it a 
little more 
painful (4) 
No effect 
(3) 
Makes it a 
little 
better (2) 
Makes it a 
lot better 
(1) 
7. Please indicate the effect of eating or drinking 
something COLD:      
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Please indicate the extent to which Not at all (1) 
A small 
extent (2) 
Moderate 
extent (3) 
A large 
extent (4) 
Complete 
extent (5) 
8. your gums have been swollen now or have 
been swollen recently:      
      
9. the tooth where you have the pain from feels 
loose: 
     
      
10.  it is difficult to swallow now or has been 
difficult to swallow recently:      
      
11. the tooth where you have the pain from feels 
like it is sticking out a little:      
      
 Full  extent (5) 
A large 
extent (4) 
Moderate 
extent (3) 
A small 
extent (2) 
Not at all 
(1) 
12. Please indicate the extent to which you have 
had difficulties with sleeping: 
     
 
13. Which of the following word(s), if any, would you use to describe your current 
pain? Yes (1) No (0) 
Exhausting   
Electric shocks   
Pulling   
Numb   
 
14. What other word(s), if any, would you use to describe your current pain? Please write in the space 
below: 
 
The scoring by question is shown in parenthesis behind each response item. Each of 
the three diagnostic groups have Fisher coefficients associated with each question. To 
calculate a diagnostic group’s score firstly multiply each item response score by the 
Fisher coefficient for that question and then sum the products across all questions in order 
to generate a total score for that diagnostic group. This then should be repeated twice 
27 
more using the remaining two diagnostic group’s relevant Fisher coefficients in order to 
generate the total scores for the other two diagnostic groups. The diagnostic group with 
the highest score is the positive group i.e. the result of the screening.  
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Appendix&2:&TMD&screener&
Question 1. In the last 30 days, on average, how long did any pain last in your jaw or temple area on either side? 
a) No pain b) From very brief to more than a week but it does stop c) Continuous 
   
 
Question 2. In the last 30 days, have you had pain or stiffness in your jaw on awakening? 
a) No b) Yes 
  
 
 
Questions 3-6. In the last 30 days, did the following activities change any pain (that is, make it better OR make it 
worse) in your jaw or temple region on either side? 
 
 a) No b) Yes 
3. Chewing hard or tough food   
4. Opening your mouth or moving your jaw forward or to the side   
5. Jaw habits such as holding teeth together, clenching/grinding, or chewing gum   
6. Other jaw activities such as talking, kissing, or yawning   
 
Questions 1, 2, and 3 constitute the three-item TMD screener. 
 
Scoring of the questionnaire is 0 for each a) response, 1 for each b) response, and 2 for 
the lone c) response. The threshold values for a positive score are 2 for the short version 
and 3 for the long version. 
